Abnormal 0 8 0 8 O
electroencephalogram 9 29 9 29 B-clinical_variable
in 30 32 30 32 O
the 33 36 33 36 O
past 37 41 37 41 O
month 42 47 42 47 O

Ages 0 4 48 52 B-age
4 5 6 53 54 B-lower_bound
to 7 9 55 57 O
17 10 12 58 60 B-upper_bound
1/2 13 16 61 64 I-upper_bound
years 17 22 65 70 I-upper_bound

Asthma 0 6 71 77 B-chronic_disease

Cardiovascular 0 14 78 92 B-chronic_disease
problems 15 23 93 101 I-chronic_disease

Children 0 8 102 110 O
on 9 11 111 113 O
these 12 17 114 119 O
will 18 22 120 124 O
have 23 27 125 129 O
to 28 30 130 132 O
discontinue 31 42 133 144 O
them 43 47 145 149 O
for 48 51 150 153 O
4 52 53 154 155 B-lower_bound
weeks 54 59 156 161 I-lower_bound
before 60 66 162 168 O
enrollment 67 77 169 179 O
in 78 80 180 182 O
the 81 84 183 186 O
trial 85 90 187 192 O
in 91 93 193 195 O
order 94 99 196 201 O
to 100 102 202 204 O
establish 103 112 205 214 O
an 113 115 215 217 O
appropriate 116 127 218 229 O
behavioral 128 138 230 240 O
baseline 139 147 241 249 O
, 147 148 249 250 O
and 149 152 251 254 O
agree 153 158 255 260 O
to 159 161 261 263 O
discontinue 162 173 264 275 O
use 174 177 276 279 O
for 178 181 280 283 O
the 182 185 284 287 O
duration 186 194 288 296 O
of 195 197 297 299 O
the 198 201 300 303 O
trial 202 207 304 309 O

Diagnosis 0 9 310 319 O
with 10 14 320 324 O
Autism 15 21 325 331 B-chronic_disease
Spectrum 22 30 332 340 I-chronic_disease
Disorder 31 39 341 349 I-chronic_disease
on 40 42 350 352 O
the 43 46 353 356 O
basis 47 52 357 362 O
of 53 55 363 365 O
the 56 59 366 369 O
clinical 60 68 370 378 O
judgment 69 77 379 387 O
of 78 80 388 390 O
an 81 83 391 393 O
autism 84 90 394 400 O
specialist 91 101 401 411 O
, 101 102 411 412 O
preferably 103 113 413 423 O
using 114 119 424 429 O
the 120 123 430 433 O
Autism 124 130 434 440 B-treatment
Diagnostic 131 141 441 451 I-treatment
Observation 142 153 452 463 I-treatment
Schedule 154 162 464 472 I-treatment
or 163 165 473 475 O
the 166 169 476 479 O
Autism 170 176 480 486 B-treatment
Diagnostic 177 187 487 497 I-treatment
Interview 188 197 498 507 I-treatment
- 197 198 507 508 I-treatment
Revised 198 205 508 515 I-treatment

Drugs 0 5 516 521 O
that 6 10 522 526 O
induce 11 17 527 533 O
or 18 20 534 536 O
inhibit 21 28 537 544 O
cytochrome 29 39 545 555 O
P450 40 44 556 560 O
2D6 45 48 561 564 O
and 49 52 565 568 O
cytochrome 53 63 569 579 O
P450 64 68 580 584 O
3A4 69 72 585 588 O
( 73 74 589 590 O
enzymes 74 81 590 597 O
important 82 91 598 607 O
for 92 95 608 611 O
drug 96 100 612 616 O
metabolism 101 111 617 627 O
) 111 112 627 628 O
will 113 117 629 633 O
be 118 120 634 636 O
allowed 121 128 637 644 O
because 129 136 645 652 O
any 137 140 653 656 O
effects 141 148 657 664 O
of 149 151 665 667 O
such 152 156 668 672 O
medications 157 168 673 684 B-treatment
are 169 172 685 688 O
likely 173 179 689 695 O
to 180 182 696 698 O
be 183 185 699 701 O
lost 186 190 702 706 O
in 191 193 707 709 O
individual 194 204 710 720 O
variability 205 216 721 732 O
due 217 220 733 736 O
to 221 223 737 739 O
genetic 224 231 740 747 O
polymorphisms 232 245 748 761 O

Other 0 5 762 767 O
serious 6 13 768 775 B-chronic_disease
illness 14 21 776 783 I-chronic_disease

Peptic 0 6 784 790 B-chronic_disease
ulcer 7 12 791 796 I-chronic_disease
disease 13 20 797 804 I-chronic_disease

Pregnancy 0 9 805 814 B-pregnancy
and 10 13 815 818 O
lactation 14 23 819 828 O

Renal 0 5 829 834 B-chronic_disease
or 6 8 835 837 O
hepatic 9 16 838 845 B-chronic_disease
dysfunction 17 28 846 857 I-chronic_disease
( 29 30 858 859 O
abnormal 30 38 859 867 O
blood 39 44 868 873 O
urea 45 49 874 878 O
nitrogen 50 58 879 887 O
/ 58 59 887 888 O
creatinine 59 69 888 898 O
or 70 72 899 901 O
2 73 74 902 903 O
times 75 80 904 909 O
elevated 81 89 910 918 O
liver 90 95 919 924 O
transaminases 96 109 925 938 O
) 109 110 938 939 O

Respiratory 0 11 940 951 B-chronic_disease
disease 12 19 952 959 I-chronic_disease

Underweight 0 11 960 971 B-clinical_variable
( 12 13 972 973 O
body 13 17 973 977 B-bmi
mass 18 22 978 982 I-bmi
index 23 28 983 988 I-bmi
< 29 30 989 990 O
5th 31 34 991 994 B-upper_bound
percentile 35 45 995 1005 I-upper_bound
compared 46 54 1006 1014 O
to 55 57 1015 1017 O
age 58 61 1018 1021 B-age
and 62 65 1022 1025 O
sex 66 69 1026 1029 O
matched 70 77 1030 1037 O
population 78 88 1038 1048 O
) 88 89 1048 1049 O

Urinary 0 7 1050 1057 B-chronic_disease
tract 8 13 1058 1063 I-chronic_disease
obstruction 14 25 1064 1075 I-chronic_disease

Use 0 3 1076 1079 O
of 4 6 1080 1082 O
any 7 10 1083 1086 O
of 11 13 1087 1089 O
the 14 17 1090 1093 O
following 18 27 1094 1103 O
drugs 28 33 1104 1109 O
that 34 38 1110 1114 O
might 39 44 1115 1120 O
interact 45 53 1121 1129 O
with 54 58 1130 1134 O
study 59 64 1135 1140 B-treatment
medications 65 76 1141 1152 I-treatment
( 77 78 1153 1154 O
anticholinergics 78 94 1154 1170 B-treatment
, 94 95 1170 1171 O
systemic 96 104 1172 1180 B-treatment
corticosteroids 105 120 1181 1196 I-treatment
, 120 121 1196 1197 O
phenobarbital 122 135 1198 1211 B-treatment
, 135 136 1211 1212 O
peginterferon 137 150 1213 1226 B-treatment
, 150 151 1226 1227 O
beta 152 156 1228 1232 B-treatment
- 156 157 1232 1233 I-treatment
blockers 157 165 1233 1241 I-treatment
or 166 168 1242 1244 O
any 169 172 1245 1248 O
drug 173 177 1249 1253 O
that 178 182 1254 1258 O
may 183 186 1259 1262 O
cause 187 192 1263 1268 O
arrhythmias 193 204 1269 1280 B-chronic_disease
) 204 205 1280 1281 O

Use 0 3 1282 1285 O
of 4 6 1286 1288 O
medications 7 18 1289 1300 O
affecting 19 28 1301 1310 O
sleep 29 34 1311 1316 O
( 35 36 1317 1318 O
including 36 45 1318 1327 O
melatonin 46 55 1328 1337 B-treatment
or 56 58 1338 1340 O
donepezil 59 68 1341 1350 B-treatment
) 68 69 1350 1351 O

female 0 6 1352 1358 B-gender
children 7 15 1359 1367 O

male 0 4 1368 1372 B-gender

